Breaking News

Amatsigroup Manufactures Injectable Clinical Batch Under Single-Use Isolator

French CDMO develops innovative single-use technology solutions for aseptic formulation & manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Amatsigroup, a contract development and manufacturing Organization (CDMO) located in France, unveiled what it says is the world’s first-in-class manufacturing of a clinical injection batch under single-use isolator, a major global breakthrough currently to be used in the treatment of acute ischemic stroke. In January 2017, Amatsigroup acquired Disposable Lab, which specializes in the production of small batches of pharmaceutical drug products in Martillac, France. The design of the production...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters